Medical devices, healthcare technology and the business of care
510(k) clearance · K254028

Digital Color Doppler Ultrasound System (Autra RS, Autra 90, Autra Senior, Autra CV, e-Autra, Autra 75, Autra 85W, Autra 65, Autra 55, Autra 65i, Autra 90 Elite, Autra 85 Elite, Autra 80 Elite, Autra 75 Elite, Autra 85 CV, Autra 80W, Autra 65 Elite, Autra 55 Elite, Autra 55i, Autra 90 CV, Autra 85, Autra 80, Autra 80 CV, Autra 75 Pro, Autra 75W, Autra 70 Elite, Autra 70, Autra T)

SONOSCAPE MEDICAL CORP. · Decision date May 15, 2026

FDA DECISIONK254028

What did the FDA decide?

FDA records K254028 as a 510(k) premarket notification, with a decision dated May 15, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
May 15, 2026

FDA source record

Regulatory record facts

Identifier
K254028
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
May 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K254028 received

    Application receipt date recorded by FDA.

  2. K254028 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 16, 2026FDA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 8, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceOct 8, 2026FDA
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC510(k) clearanceOct 2, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

SONOSCAPE MEDICAL CORP.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records